Jérôme Becquart

Neurokin is a venture-back bio-tech company based in Marseilles, France. Neurokin is specializing in the development of different pharmacological in vitro platforms and in vivo experimental models related to acute neurological diseases. Neurokin's major objective is to identify new CDK inhibitors as neuroprotectants. Neurokin focuses on stroke, epilepsy, cerebral hypoxia after cardiac arrest and traumatic brain injury. As of May 2009, Neurokin has identified new neuroprotective drug candidates and has brought them to the regulatory preclinical stage.

ActivIdentity Corp. provides identity solutions which are designed to enable customers to confidently establish trust in online activities. The company offers its authentication and credential management solutions to the field of online banking and to government organizations. ActivIdentity was founded in 1987. Its headquarters are located in Fremont, CA.

GlobalPlatform, Inc. is a technical standards organization that provides standardized technologies and certifications to empower technology and service providers to develop, certify, deploy, and manage digital services and devices in line with their business, security, regulatory and data protection needs. The non-profit company is based in Redwood City, CA. Its platform technologies are used in billions of smart cards, smartphones, wearables and other connected IoT devices. The company achieves end-to-end security, privacy, simplicity, and convenience to users by enabling the efficient launch and management of innovative, secure-by-design digital services and devices. The company's standardized technologies and certifications are developed through effective industry-driven collaboration, led by multiple diverse member companies working in partnership with industry and regulatory bodies and other interested parties from around the world.

VeriFone Systems, Inc. engages in the provision of payment solutions. It serves retail, hospitality, acquirers, and convenience and petro. The company was founded on June 13, 2002 and is headquartered in San Jose, CA.

BrainVectis SAS provides gene therapy services. It develops gene therapy treatments for neurodegenerative diseases by targeting the cholesterol pathway in the brain to restore cholesterol metabolism. The company was founded by Nathalie Cartier-Lacave and Jérôme Becquart in 2015 and is headquartered in Paris, France.

Axiad IDS, Inc. provides passwordless orchestration for enterprise and public sector organizations to secure people, machines, and interactions. The company is based in Santa Clara, CA. The company's flagship product, Axaid Cloud, is a comprehensive, secure, and integrated authentication platform that allows customers to move to a passwordless future without the friction and risk of fragmented solutions. Axaid offers unified credential management for all employees' authentication needs, including certificates, mobile MFA, TPM, hardware tokens, smart cards, and biometrics. The company was founded in 2010 by Yves Audebert and Bassam Al-Khalidi, and they have been the CEOs since 2010.